Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
NA-931, a novel quadruple IGF-1, GLP-1, GIP and glucagon receptor agonist reduces body weight without muscle loss (NA-931, a novel quadruple IGF-1, GLP-1 and GIP incretin receptor agonist reduces body weight without muscle loss | Obesity Conferences 2024 | Weight Management Conferences 2024 | Obesity Events 2024 | Weight Management Congress | Obesity Conference) (NA-931, a novel quadruple IGF-1, GLP-1 and GIP incretin receptor agonist reduces body weight without muscle loss | Obesity Conferences 2024 | Weight Management Conferences 2024 | Obesity Events 2024 | Weight Management Congress | Obesity Conference)
Will this data be compelling enough to move payers
For those focused on gut and general health, we often suggest looking at panels that include markers for inflammation, thyroid function, and key nutrients
Para continuar, ingresa atu cuenta trace-id: 2dcc256d-2158-4875-b8e3-5b515ad3d068 Usamos cookies para mejorar tu experiencia en Mercado Libre
US$ 25.11
US$ 20.43
US$ 26.34
US$ 23.42
